MaxCyte, Inc. Interest Costs Capitalized
MaxCyte, Inc. (MXCT) reported Interest Costs Capitalized of $0 for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InterestCostsCapitalized · last filed 2021-11-10
- MaxCyte, Inc. interest costs capitalized for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- MaxCyte, Inc. interest costs capitalized for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- MaxCyte, Inc. interest costs capitalized for the quarter ending 2020-09-30 was $3.80K.
- MaxCyte, Inc. interest costs capitalized for the quarter ending 2020-06-30 was $5.70K.
| Period end | Interest Costs Capitalized 3 month | Interest Costs Capitalized 6 month | Interest Costs Capitalized 9 month |
|---|---|---|---|
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 |
| 2021-06-30 | $0.00 10-Q · filed 2021-09-13 | $0.00 10-Q · filed 2021-09-13 | |
| 2020-09-30 | $3.80K 10-Q · filed 2021-11-10 | $9.50K derived: sum of 2 quarters · filed 2021-11-10 | $12.10K 10-Q · filed 2021-11-10 |
| 2020-06-30 | $5.70K 10-Q · filed 2021-09-13 | $8.20K 10-Q · filed 2021-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |